CGI
BRLI

CI Global Investments’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

CI Global Investments’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-275,000
Closed -$7.02M – 243
2013
Q4 		$7.02M Buy
+275,000
New +$8.47M 0.2% 109

Other funds holding BRLI

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CI Global Investments's BRLI Position: Q1 2014 in Review

CI Global Investments sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 275,000 shares — an estimated $7.02M sold.

CI Global Investments first reported a position in BRLI in Q4 2013 and held it in 1 quarter. The position peaked at $7.02M in Q4 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • CI Global Investments reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • CI Global Investments sold 275,000 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $7.02M.
  • CI Global Investments first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 1 quarter.
  • CI Global Investments's BIO-REFERENCE LABS INC-NEW- position peaked at $7.02M in Q4 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on CI Global Investments's 13F filing for Q1 2014, filed 6 May 2014.